The Evaluation of Glycyrrhizic Acid's Pesticide Effect in Treating Liver Damage (Retrospective Study）

Beta Glucosylceramide for Treatment of NASH

NCT02126306 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy and Safety of Glucocorticosteroid Treatment in the Patients With Chronic Recurrent DILI

NCT02651350 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy and Safety of Fermented Ginseng Powder on Liver Function

NCT03260543 ·Status: COMPLETED ·Phase: NA

The Effect of Rifaximin on Portal Vein Thrombosis

NCT03631147 ·Status: UNKNOWN ·Phase: NA

A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body

NCT02538874 ·Status: COMPLETED ·Phase: PHASE1

Effect of Ginger Supplement on Non-alcoholic Fatty Liver

NCT02535195 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo

NCT05144217 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy of Plasmapheresis in Patients of Drug-Induced Liver Injury (DILI) With Underlying Chronic Liver Disease

NCT06797011 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

Probiotic Supplement Versus Placebo for the Treatment of Patients With Non-alcoholic Fatty Liver Disease

NCT06491342 ·Status: COMPLETED ·Phase: NA

Efficacy of Oral Trigonella Foenum-graecum Seed Extract Vs Placebo in Treatment of None Alcoholic Fatty Liver Disease

NCT02303314 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of HSK21542 Injection in Liver Disease Subjects With Pruritus

NCT04999787 ·Status: COMPLETED ·Phase: PHASE2

a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease（NAFLD）

NCT07128797 ·Status: RECRUITING ·Phase: PHASE1

F573 for Injection for the Treatment of Liver Injury/Failure

NCT05689645 ·Status: RECRUITING ·Phase: PHASE2

The Effect of GLP-1 Analogues on Liver Steatosis and Fibrosis in Diabetic and Obese Patients in a Clinical Setting

NCT07021443 ·Status: COMPLETED

Investigation on Safety and Efficacy of Soybean Fermented Extract (MBS217) in Treating Patients With NAFLD

NCT05686174 ·Status: UNKNOWN ·Phase: PHASE1

Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal Varices

NCT02508623 ·Status: UNKNOWN ·Phase: PHASE3

Alterations of Gut Microbiota and Serum Biochemical Markers in DILI Patients

NCT05465642 ·Status: UNKNOWN

Acamprosate Safe to Use in Individuals With Liver Disease.

NCT04287920 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver Cirrhosis

NCT01728688 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease

NCT02927314 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

NCT06773221 ·Status: NOT_YET_RECRUITING ·Phase: NA

Fuzheng Huayu Tablets Reduce the Occurrence of Re-Decompensation Events in Patients With First Decompensation of Hepatitis B-Related Liver Cirrhosis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

NCT07017426 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Study in Subjects With Liver Function Injury and Subjects With Normal Liver Function

NCT06093230 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver Disease

NCT06272630 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH

NCT05462353 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2